Improving medication-related outcomes for patients with psychiatric and neurologic disorders: Value of psychiatric pharmacists as part of the health care team

Lisa W Goldstone, B. DiPaula, J. Caballero, Susie H Park, Cristofer Price, M. Slater
{"title":"Improving medication-related outcomes for patients with psychiatric and neurologic disorders: Value of psychiatric pharmacists as part of the health care team","authors":"Lisa W Goldstone, B. DiPaula, J. Caballero, Susie H Park, Cristofer Price, M. Slater","doi":"10.9740/MHC.2015.01.001","DOIUrl":null,"url":null,"abstract":"Psychiatric pharmacists have specialized knowledge, skills, and training or substantial experience working with patients with psychiatric or neurologic disorders. As part of the collaborative team with a physician, psychiatric pharmacists can provide comprehensive medication management (CMM), a direct patient care service, to patients with psychiatric or neurologic disorders. CMM is a standard of care in which all medications for an individual patient are assessed to determine appropriateness, effectiveness, safety, and adherence. Studies have shown that when psychiatric pharmacists are included as part of the collaborative team with a physician, medication-related outcomes for patients with psychiatric or neurologic disorders improve. Despite the evidence supporting the value of psychiatric pharmacists as part of the health care team, the very limited mechanisms for compensation for CMM limit the numbers of patients with psychiatric or neurologic disorders who have access to services provided by a psychi...","PeriodicalId":18691,"journal":{"name":"Mental Health Clinician","volume":"5 1","pages":"1-28"},"PeriodicalIF":0.0000,"publicationDate":"2015-01-27","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"36","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Mental Health Clinician","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.9740/MHC.2015.01.001","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 36

Abstract

Psychiatric pharmacists have specialized knowledge, skills, and training or substantial experience working with patients with psychiatric or neurologic disorders. As part of the collaborative team with a physician, psychiatric pharmacists can provide comprehensive medication management (CMM), a direct patient care service, to patients with psychiatric or neurologic disorders. CMM is a standard of care in which all medications for an individual patient are assessed to determine appropriateness, effectiveness, safety, and adherence. Studies have shown that when psychiatric pharmacists are included as part of the collaborative team with a physician, medication-related outcomes for patients with psychiatric or neurologic disorders improve. Despite the evidence supporting the value of psychiatric pharmacists as part of the health care team, the very limited mechanisms for compensation for CMM limit the numbers of patients with psychiatric or neurologic disorders who have access to services provided by a psychi...
查看原文
分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
改善精神和神经系统疾病患者的药物相关结果:精神科药剂师作为卫生保健团队一部分的价值
精神科药剂师有专门的知识、技能和训练,或与精神或神经障碍患者一起工作的丰富经验。作为与内科医生合作团队的一部分,精神科药剂师可以为患有精神或神经疾病的患者提供综合药物管理(CMM),这是一种直接的患者护理服务。CMM是一种标准的护理方法,其中对单个患者的所有药物进行评估,以确定适当性、有效性、安全性和依从性。研究表明,当精神科药剂师被纳入与医生合作的团队时,精神或神经疾病患者的药物相关结果会得到改善。尽管有证据支持精神科药剂师作为卫生保健团队的一部分的价值,但CMM的补偿机制非常有限,限制了精神病或神经系统疾病患者能够获得精神科医生提供的服务的人数。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 去求助
来源期刊
自引率
0.00%
发文量
0
期刊最新文献
Pharmacologic treatment of bipolar disorder and comorbid adult attention-deficit/hyperactivity disorder Training student pharmacists to administer long-acting injectable medications AAPP 2024 Annual Meeting Poster Abstracts Clozapine clinical toolkit optimizes inpatient clozapine monitoring Evidence and clinical considerations for the use of serotonin and norepinephrine reuptake inhibitors for the treatment of painful neuropathy
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1